mevalonic acid has been researched along with Gammapathy, Monoclonal in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Belloni, D; Caligaris-Cappio, F; Ferrarini, M; Ferrero, E; Fortis, C; Girlanda, S; Groh, V; Sciorati, C; Spies, T; Ticozzi, P; Tresoldi, M; Vicari, A | 1 |
1 other study(ies) available for mevalonic acid and Gammapathy, Monoclonal
Article | Year |
---|---|
MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Diphosphonates; Female; Histocompatibility Antigens Class I; Humans; Lymphocyte Activation; Male; Mevalonic Acid; Middle Aged; Multiple Myeloma; Pamidronate; Paraproteinemias; Plasma Cells; Receptors, Antigen, T-Cell, gamma-delta; T-Lymphocytes | 2005 |